-
1.
公开(公告)号:WO2023057875A1
公开(公告)日:2023-04-13
申请号:PCT/IB2022/059416
申请日:2022-10-03
IPC分类号: G01N33/68 , B01L3/00 , G01N27/447 , G01N2333/48 , G01N2800/2814 , G01N2800/2821 , G01N2800/2835 , G01N2800/285 , G01N33/6896
摘要: Method for the early diagnosis and the monitoring of the evolution/regression of neurodegenerative pathologies, said method providing for the quantification of a. biomarker for said pathologies in a fluid that was previously drawn from a. patient, said fluid being selected from among: cerebrospinal fluid; serum; urine; post mortem cerebral tissues and cellular lysates, said method being characterized in that the quantified biomarker is selected from among native proNGF; modified proNGF, the latter being proNGF in its forms with higher molecular weight, including forms of 39-40 kDa and 45-50kDa; NGF; and the proNGF/NGF ratio, said method sequentially providing for the fol lowing steps of Preparation of the biological sample, Definition of the calibration curve; Execution of run and interpolation.
-
公开(公告)号:WO2023004784A1
公开(公告)日:2023-02-02
申请号:PCT/CN2021/109763
申请日:2021-07-30
申请人: 成都优洛生物科技有限公司
IPC分类号: C12N5/10 , C12N15/12 , C12N15/85 , C12R1/91 , C07K14/48 , C07K14/70517 , C07K2319/03 , C12N15/86 , C12N2510/00 , C12N2740/15043 , C12N2800/107 , C12N2800/22 , C12N5/0682 , G01N2333/48 , G01N33/56966 , G01N33/581 , G01N33/6854
摘要: 提供了一种重组CHO细胞及其构建方法、包含该重组CHO细胞的检测系统以及利用该重组CHO细胞的检测方法。该重组CHO细胞在其细胞表面上稳定表达NGF,能够用作ADCC效应和CDC效应检测的靶细胞。
-
公开(公告)号:WO2022028354A1
公开(公告)日:2022-02-10
申请号:PCT/CN2021/109995
申请日:2021-08-02
申请人: 杭州熙源生物技术有限公司
IPC分类号: C07K16/22 , C07K16/46 , C07K19/00 , C12N15/13 , C12N15/63 , C12N5/00 , A61K39/395 , A61K47/68 , A61P19/02 , A61P29/00 , A61P19/08 , A61P35/00 , A61P25/00 , G01N33/68 , A61K2039/505 , A61K47/6801 , C07K14/7051 , C07K2317/24 , C07K2317/31 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/33 , G01N2333/48 , G01N33/74
摘要: 本发明提供了一种抗NGF抗体或其抗原结合片段、其制备方法和应用;本发明还提供了编码所述抗NGF抗体或其抗原结合片段的分离的多核苷酸,以及包含所述分离的多核苷酸的载体。本发明还提供了本发明的抗体或其抗原结合片段在制备用于治疗NGF介导的疾病或病症的药物中的用途。
-
-